Pay in 4 interest-free payments of $5.87 Learn more
Ships within 48 hours · Estimated delivery Nov 8 - Nov 13
At its core, this product contains 500 mcg of BPC-157 per capsule, designed to support injury recovery, gastrointestinal health, and collagen synthesis
Your Lounge
A phase 1b randomised controlled trial of a glucagon-like peptide-1 and glucagon receptor dual agonist IBI362 (LY3305677) in Chinese patients with type 2 diabetes
Mounting studies have confirmed that the TME promotes cancer progression in many aspects, especially therapeutic resistance
It goes one step further as a triple-agonist, targeting GLP-1, GIP, and glucagon receptors, which may enhance fat metabolism
US$ 20.88
US$ 26.28
US$ 20.04
US$ 23.55
